Report from Thailand - The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness. - BioPharm International

ADVERTISEMENT

Report from Thailand
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.


BioPharm International
Volume 26, Issue 4, pp. 8-9

IMPORTANT FACTS

  • Under Thailand's first National Biotechnology Policy Framework (2004 to 2009), 90 new companies were formed, bringing the number of biotech companies to an estimated total of 170.
  • Thailand has succeeded in producing the world's first commercial biosensor for avian influenza. Currently, it is in the process of producing its first indigenous drug to treat malaria. If successful, it will be a breakthrough development that puts Thailand on the world map.
  • Thailand is regarded as a prime "pharmerging market" due to the potential of its biotech sector. The large population and academic/healthcare infrastructure make the country an ideal provider of clinical trials.

—Jane Wan is a freelance writer based in Singapore.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here